Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Can J Psychiatry. 1994 Mar;39(2):74-84.

Antiparkinsonian drugs in the treatment of neuroleptic-induced extrapyramidal symptoms.

Author information

  • 1Clarke Institute of Psychiatry, Toronto, Ontario.

Abstract

Most patients on neuroleptic therapy experience extrapyramidal symptoms in one form or another during treatment. While the risk of extrapyramidal symptoms appears diminished with the newer and "atypical" neuroleptics (for example, risperidone, remoxipride, clozapine), it is not eliminated. It is essential that the treating clinician monitor for such side effects since if they are left untreated they can be an ongoing source of discomfort to the patient and may affect compliance with therapy. Antiparkinsonian medication represents the mainstay of treatment for neuroleptic-induced extrapyramidal symptoms. Their clinical use is reviewed here with reference to mode of action, indications, choice, side-effects and precautions.

PMID:
7908605
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Write to the Help Desk